To deliver on the promise of eradicating HIV will require a commitment to science, properly funded public health treatment and prevention programs, and policies that support all populations impacted by HIV. It will also require access to affordable and comprehensive health coverage, including private insurance, Medicaid and Medicare.
The HIV+Hepatitis Policy Institute, a leading national HIV and hepatitis policy organization promoting quality and affordable healthcare for people living with or at risk for HIV, hepatitis, and other serious and chronic health conditions, is urging senators to ensure that Robert F. Kennedy Jr., President Trump’s nominee to be Secretary of Health and Human Services, will uphold a commitment to science, public health, and ending HIV through robust research, treatment, and prevention programs.
As the U.S. prepares to welcome a new presidential administration, leaders from business, public health, and community organizations gathered in Atlanta last week to reaffirm their dedication to ending the HIV epidemic and improving access to prevention and care.
“Because of years of research and scientific advancements, we now have the tools to prevent and treat HIV and keep people living healthy and long lives,” said Carl Schmid, executive director of HIV+Hepatitis Policy Institute. “Now is not the time to retreat on our commitment to protecting the health of our nation. President Trump initiated the Ending the HIV Epidemic initiative in his first term, which was sustained by President Biden and his administration. Now we look forward to that same commitment from President Trump as he and his new administration seek to make our country healthier, bolster prevention, and address chronic diseases.”
The American people have spoken and elected Donald Trump and JD Vance as our next President and Vice President. The HIV+Hepatitis Policy Institute will work with the new administration on furthering efforts to end HIV and hepatitis in the United States. With proper leadership, policies, and funding, we can end both these infectious diseases.